BAFNA PHARMA Share Price
NSE: BAFNAPH|BSE: 532989|Pharmaceuticals₹138.19
+₹6.58 (5.00%) As on 19 Sep, 2025 | 15:27 ISTBAFNA PHARMA Stock Performance
Market cap  ₹327 Crs | Open ₹138.19 | Prev. Close ₹131.61 |
Circuit range ₹145.09 - ₹131.28 | Day range ₹125.70 - ₹138.19 | Year range ₹69.00 - ₹138.19 |
Volume 94,548 | Avg. traded ₹137.16 | Revenue (12m) ₹147 Crs |
About BAFNA PHARMA
Bafna Pharmaceuticals Limited is an India-based company, which is engaged in manufacturing of pharmaceutical formulations. The Company exports its products to the Europe, the United Kingdom, Australia, Sri Lanka, Africa, and Commonwealth countries.
As of last trading day, BAFNA PHARMA opened at ₹138.19 and last traded at ₹138.19, showing a rise of 6.58 points (5.00%) compared to the previous close of ₹131.61. During the session, the stock touched a high of ₹138.19 and a low of ₹125.70. The company's market capitalization now stands at ₹327 Crs, with a P/E ratio of 42.6 and a dividend yield of 0.00%.
21 September 2025 – BAFNA PHARMA Share Price Update
As of last trading day, BAFNA PHARMA opened at ₹138.19 and last traded at ₹138.19, showing a rise of 6.58 points (5.00%) compared to the previous close of ₹131.61. During the session, the stock touched a high of ₹138.19 and a low of ₹125.70. The company's market capitalization now stands at ₹327 Crs, with a P/E ratio of 42.6 and a dividend yield of 0.00%.BAFNA PHARMA Share Price Chart
₹138.19+₹6.58 (5.00%)
Please wait...
BAFNA PHARMA Key Indicators
P/E ratio 42.61 | P/B ratio 2.09 | ROE 4.98% |
ROCE 5.82% | Dividend yield -- | Debt/Equity ratio 0.32 |
EPS 1.76 |
Investment Checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
BAFNA PHARMA Financial Ratios
Operating profit margin9.59% | Net profit margin4.37% |
ROE4.98% | ROA3.6% |
ROCE5.82% |
Quick ratio1.09 | Current ratio1.69 |
Interest coverage3.33 | Asset turnover1.44 |
Debt to Equity0.32 |
P/E ratio42.61 | P/B ratio2.09 |
EV / EBITDA17.18 | |
Dividend yield0% |
BAFNA PHARMA Revenue Statement
All values are in ₹ Crores (Cr)
Year  | Revenue  | Operating Profit | Net Profit |
|---|---|---|---|
Mar-19 | ₹44.01 | ₹-17.28 | ₹-18.35 |
Mar-18 | ₹78.50 | ₹-14.72 | ₹-16.91 |
Mar-17 | ₹66.10 | ₹-20.36 | ₹-19.46 |
Mar-16 | ₹87.30 | ₹-15.32 | ₹-15.14 |
BAFNA PHARMA Cash Flow
All values are in ₹ Crores (Cr)
Year | Operating | Investing | Financing |
|---|---|---|---|
Mar-20 | ₹-34.31 | ||
Mar-19 | ₹-1.79 | ₹-13.81 | |
Mar-18 | ₹-7.05 | ₹-30.63 | |
Mar-17 | ₹-0.95 | ₹-5.42 |
BAFNA PHARMA Balance Sheet
All values are in ₹ Crores (Cr)
Period | Total Asset | Total Liability |
|---|---|---|
Mar-20 | ₹71.31 | ₹20.12 |
Mar-19 | ₹119.47 | ₹100.62 |
Mar-18 | ₹138.36 | ₹101.16 |
Mar-17 | ₹178.31 | ₹136.20 |
BAFNA PHARMA Share Price History
| Day | Open | Close | Change % |
|---|---|---|---|
05-Sep-25 | ₹103.11 | ₹100.72 | |
04-Sep-25 | ₹107.80 | ₹99.97 | -2.91% |
03-Sep-25 | ₹106.00 | ₹102.97 | -1.79% |
02-Sep-25 | ₹106.00 | ₹104.85 | |
01-Sep-25 | ₹107.00 | ₹104.84 | |
29-Aug-25 | ₹103.90 | ₹103.86 | |
28-Aug-25 | ₹105.44 | ₹99.29 | -1.13% |
26-Aug-25 | ₹97.00 | ₹100.42 |
Stocks Similar to BAFNA PHARMA
Stock Name | Price | Change % |
|---|---|---|
| Albert David | ₹802.05 | -₹8.65 (-1.07%) |
| BROOKS LABORATORIES | ₹149.37 | -₹0.55 (-0.37%) |
| JENBURKT PHARMACEUTICALS LTD | ₹1,107.55 | -₹14.40 (-1.28%) |
| KILITCH DRUGS | ₹359.90 | -₹3.95 (-1.09%) |
| Lasa Supergenics | ₹13.13 | -₹0.32 (-2.38%) |
| Sakar Healthcare | ₹343.70 | +₹1.80 (0.53%) |
| SMRUTHI ORGANICS LIMITED | ₹140.50 | +₹3.65 (2.67%) |
| SMS Lifesciences | ₹1,184.50 | -₹39.60 (-3.24%) |
| WANBURY LIMITED | ₹250.25 | -₹8.35 (-3.23%) |
Popular Stocks
Stock Name | Price | Change % |
|---|---|---|
| Indian Oil Corp Share Price | ₹148.50 | +₹1.35 (0.92%) |
| Indian Railway Finance Corp Share Price | ₹129.69 | +₹0.40 (0.31%) |
| Jaiprakash Power Ventures Share Price | ₹18.68 | -₹0.15 (-0.8%) |
| Suzlon Share Price | ₹60.40 | +₹1.32 (2.23%) |
| Tata Motors Share Price | ₹707.45 | -₹3.75 (-0.53%) |
| Tata Power Share Price | ₹396.30 | +₹3.20 (0.81%) |
| Tata Steel Share Price | ₹171.48 | -₹0.55 (-0.32%) |
| Trident Share Price | ₹30.12 | +₹0.25 (0.84%) |
| Vodafone Idea Share Price | ₹8.40 | +₹0.56 (7.14%) |
| YES Bank Share Price | ₹21.17 | +₹0.10 (0.47%) |
BAFNA PHARMA Share Price FAQs
What is the share price of BAFNA PHARMA today?
BAFNA PHARMA share price is ₹ 138.19 as on Sep, 2025 | 15:27 IST.
What are the high & low stock price of BAFNA PHARMA today?
BAFNA PHARMA stock price hit a high of ₹ 138.19 and low of ₹ 125.70 as on Sep, 2025 | 15:27 IST.
What is the market cap of BAFNA PHARMA?
The market cap of BAFNA PHARMA is ₹ 326.91 Crores as on Sep, 2025 | 15:27 IST.
What are the the 52-week high and low share prices of BAFNA PHARMA stock on the NSE?
52-week high stock Price of BAFNA PHARMA is ₹ 138.19 and Low Price is ₹ 69.00 as on Sep, 2025 | 15:27 IST.
What are the stock symbols of BAFNA PHARMA?
The stock symbol of BAFNA PHARMA is NSE: BAFNAPH on the NSE, BSE: 532989 on the BSE, and the ISIN is INE878I01022.
Can I buy BAFNA PHARMA shares on Holidays?
No, shares of BAFNA PHARMA or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell BAFNA PHARMA shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
How to buy BAFNA PHARMA shares?
To buy BAFNA PHARMA shares,open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order
What is the PE and PB ratio of BAFNA PHARMA?
The PE and PB ratio of BAFNA PHARMA is 42.61 and 2.09 respectively, as on Sep, 2025 | 15:27 IST.
What are the returns on BAFNA PHARMA shares?
The historical returns for BAFNA PHARMA shares are 74.61 for 1 year, 32.88 for 3 year and 385.73 for 5 year.